Scribe Therapeutics Pioneers Epigenetic Silencing for Cardiovascular Disease, Navigating a Cautious Gene Editing IPO Market
In a striking juxtaposition of industrial heritage and futuristic biotechnology, Scribe Therapeutics, a burgeoning gene...
Knowledge and News for the Global Fight Against Cancer.
In a striking juxtaposition of industrial heritage and futuristic biotechnology, Scribe Therapeutics, a burgeoning gene...
In a development described as the "holy grail" of reproductive medicine, researchers at Cornell University...
Researchers at Duke-NUS Medical School have identified a crucial molecular "switch" that dictates whether pancreatic...
New research from the University of South Australia has identified a significant and previously underestimated...
CureSearch for Children’s Cancer, a leading global nonprofit focused on accelerating the development of new...
A groundbreaking fusion of 3D printing, advanced stem cell biology, and the creation of lab-grown...
Approximately 25% of women in the United States between ages 45 and 60, a critical...
An international consortium of researchers, spearheaded by the University of California San Diego, has pinpointed...
A groundbreaking study published in the Journal of the National Cancer Institute (JNCI) has revealed...
Jazz Pharmaceuticals has announced its acquisition of Actio Biosciences in an upfront deal valued at...